PAVmed Announces PortIO™ Breakthrough – Nasdaq

PAVmed Announces PortIO™ Breakthrough Nasdaq

Groundbreaking i mplantable intraosseous vascular access device achieves unprecedented maintenance-free implant duration of over 60 days in.

About The Author

Scroll to Top